chr12-128267416-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136103.3(TMEM132C):c.14G>A(p.Gly5Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000303 in 1,226,752 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001136103.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM132C | NM_001136103.3 | c.14G>A | p.Gly5Asp | missense_variant | 1/9 | ENST00000435159.3 | |
TMEM132C | XM_047429886.1 | c.14G>A | p.Gly5Asp | missense_variant | 1/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM132C | ENST00000435159.3 | c.14G>A | p.Gly5Asp | missense_variant | 1/9 | 5 | NM_001136103.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00154 AC: 231AN: 150260Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000360 AC: 1AN: 2774Hom.: 0 AF XY: 0.000585 AC XY: 1AN XY: 1708
GnomAD4 exome AF: 0.000130 AC: 140AN: 1076386Hom.: 0 Cov.: 30 AF XY: 0.000115 AC XY: 59AN XY: 514330
GnomAD4 genome AF: 0.00154 AC: 232AN: 150366Hom.: 1 Cov.: 33 AF XY: 0.00162 AC XY: 119AN XY: 73430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.14G>A (p.G5D) alteration is located in exon 1 (coding exon 1) of the TMEM132C gene. This alteration results from a G to A substitution at nucleotide position 14, causing the glycine (G) at amino acid position 5 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at